Breast Cancer
Advertisement
Panelists discuss data from the ADEPT trial, port considerations, and their hopes for the future of breast cancer therapy.
Panelists discuss how nurses can maximize opportunities for connection as they treat patients with breast cancer.
The panelists discuss clinical trial data and patient preferences surrounding subcutaneous versus IV administration routes.
Panelists discuss how subcutaneous treatments can mitigate time toxicity and improve quality of life.
Panelists discuss how treatment options have changed and if indefinite therapy is still needed for certain patients.
Panelists discuss how to help patients understand the diagnosis and navigate treatment options.
Learn how oncology nurses can be leaders in building oncofertility conversations and programs.
A new study builds upon previous research addressing complex questions surrounding pregnancy after breast cancer.
In this video, Dr. Polyak speaks about what the lectureship means to her at SABCS 2023.
In this video interview, Dr. Welm speaks about what the award means to her and her hopes for the future.
There are critical time intervals for starting systemic therapy in patients with early triple-negative breast cancer.
The annual event rate over 15 years of follow-up was 1.2% per annum for margins at least 2 mm and 1.8% for those under 2 mm.
Nearly half of young women who are breast cancer survivors experienced sexual dysfunction more than 5 years after diagnosis.
Oncology nurse navigators reported “substantial barriers to many services” for patients with breast cancer.
The prospective study evaluated the hormonal contraception use and breast cancer risk in carriers of BRCA1 or BRCA2.
The 5-year OS rates “increased steadily” for female breast cancer, but survival rates did not improve for male breast ...
A large prospective study evaluated the acceptance of universal genetic testing in patients and clinicians.
Regardless of their coping style or demographics, patients universally believed 1 thing about psychotherapy referrals.
AI software flagged suspicious screening mammography exams that an interpreting radiologist did not recall for work-up.
It evaluated patients’ emotional distress, how they perceived the quality of navigation, and their satisfaction with care.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.